Berro R - Search Results

1

Transmitted/founder and chronic HIV-1 envelope proteins are distinguished by differential utilization of CCR5.

Parker ZF, Iyer SS, Wilen CB, Parrish NF, Chikere KC, Lee FH, Didigu CA, Berro R, Klasse PJ, Lee B, Moore JP, Shaw GM, Hahn BH, Doms RW. Parker ZF, et al. Among authors: berro r. J Virol. 2013 Mar;87(5):2401-11. doi: 10.1128/JVI.02964-12. Epub 2012 Dec 26. J Virol. 2013. PMID: 23269796 Free PMC article.

2

Multiple CCR5 conformations on the cell surface are used differentially by human immunodeficiency viruses resistant or sensitive to CCR5 inhibitors.

Berro R, Klasse PJ, Lascano D, Flegler A, Nagashima KA, Sanders RW, Sakmar TP, Hope TJ, Moore JP. Berro R, et al. J Virol. 2011 Aug;85(16):8227-40. doi: 10.1128/JVI.00767-11. Epub 2011 Jun 15. J Virol. 2011. PMID: 21680525 Free PMC article.

3

V3 determinants of HIV-1 escape from the CCR5 inhibitors Maraviroc and Vicriviroc.

Berro R, Klasse PJ, Jakobsen MR, Gorry PR, Moore JP, Sanders RW. Berro R, et al. Virology. 2012 Jun 5;427(2):158-65. doi: 10.1016/j.virol.2012.02.006. Epub 2012 Mar 16. Virology. 2012. PMID: 22424737 Free PMC article.

4

Use of G-protein-coupled and -uncoupled CCR5 receptors by CCR5 inhibitor-resistant and -sensitive human immunodeficiency virus type 1 variants.

Berro R, Yasmeen A, Abrol R, Trzaskowski B, Abi-Habib S, Grunbeck A, Lascano D, Goddard WA 3rd, Klasse PJ, Sakmar TP, Moore JP. Berro R, et al. J Virol. 2013 Jun;87(12):6569-81. doi: 10.1128/JVI.00099-13. Epub 2013 Mar 6. J Virol. 2013. PMID: 23468486 Free PMC article.

5

Two HIV-1 variants resistant to small molecule CCR5 inhibitors differ in how they use CCR5 for entry.

Berro R, Sanders RW, Lu M, Klasse PJ, Moore JP. Berro R, et al. PLoS Pathog. 2009 Aug;5(8):e1000548. doi: 10.1371/journal.ppat.1000548. Epub 2009 Aug 14. PLoS Pathog. 2009. PMID: 19680536 Free PMC article.

6

Differential use of CCR5 by HIV-1 clinical isolates resistant to small-molecule CCR5 antagonists.

Henrich TJ, Lewine NR, Lee SH, Rao SS, Berro R, Gulick RM, Moore JP, Tsibris AM, Kuritzkes DR. Henrich TJ, et al. Among authors: berro r. Antimicrob Agents Chemother. 2012 Apr;56(4):1931-5. doi: 10.1128/AAC.06061-11. Epub 2012 Jan 17. Antimicrob Agents Chemother. 2012. PMID: 22252820 Free PMC article.

7

CDK13, a new potential human immunodeficiency virus type 1 inhibitory factor regulating viral mRNA splicing.

Berro R, Pedati C, Kehn-Hall K, Wu W, Klase Z, Even Y, Genevière AM, Ammosova T, Nekhai S, Kashanchi F. Berro R, et al. J Virol. 2008 Jul;82(14):7155-66. doi: 10.1128/JVI.02543-07. Epub 2008 May 14. J Virol. 2008. PMID: 18480452 Free PMC article.

8

RNA interference directed to CDK2 inhibits HIV-1 transcription.

Ammosova T, Berro R, Kashanchi F, Nekhai S. Ammosova T, et al. Among authors: berro r. Virology. 2005 Oct 25;341(2):171-8. doi: 10.1016/j.virol.2005.06.041. Epub 2005 Aug 8. Virology. 2005. PMID: 16085226 Free article.

9

Kinesin KIF4 regulates intracellular trafficking and stability of the human immunodeficiency virus type 1 Gag polyprotein.

Martinez NW, Xue X, Berro RG, Kreitzer G, Resh MD. Martinez NW, et al. Among authors: berro rg. J Virol. 2008 Oct;82(20):9937-50. doi: 10.1128/JVI.00819-08. Epub 2008 Aug 6. J Virol. 2008. PMID: 18684836 Free PMC article.

10

Acetylated Tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32.

Berro R, Kehn K, de la Fuente C, Pumfery A, Adair R, Wade J, Colberg-Poley AM, Hiscott J, Kashanchi F. Berro R, et al. J Virol. 2006 Apr;80(7):3189-204. doi: 10.1128/JVI.80.7.3189-3204.2006. J Virol. 2006. PMID: 16537587 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters